Dapaglifozin

Dapagliflozin is an SGLT2 inhibitor used to manage type 2 diabetes by lowering blood sugar through increased glucose excretion in urine.
It also supports heart failure and chronic kidney disease management by improving cardiovascular and renal outcomes.
This medication helps reduce HbA1c levels, promotes mild weight loss, and lowers blood pressure.
Dapagliflozin is widely prescribed for its dual benefits in glycemic control and long-term organ protection.